日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy

表达抗 VEGF 单链抗体的溶瘤痘苗病毒株 GLV-5b451 用于犬癌症治疗的临床前测试

Marion Adelfinger, Simon Bessler, Alexa Frentzen, Alexander Cecil, Johanna Langbein-Laugwitz, Ivaylo Gentschev, Aladar A Szalay

Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy

评估新型重组溶瘤痘苗病毒株 GLV-5b451 对猫乳腺癌的治疗效果

Marion Adelfinger, Ivaylo Gentschev, Julio Grimm de Guibert, Stephanie Weibel, Johanna Langbein-Laugwitz, Barbara Härtl, Hugo Murua Escobar, Ingo Nolte, Nanhai G Chen, Richard J Aguilar, Yong A Yu, Qian Zhang, Alexa Frentzen, Aladar A Szalay

Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer

溶瘤病毒疗法治疗实验性肺癌皮下异种移植模型中的恶性积液

Stephanie Weibel, Elisabeth Hofmann, Thomas Christian Basse-Luesebrink, Ulrike Donat, Carolin Seubert, Marion Adelfinger, Prisca Gnamlin, Christina Kober, Alexa Frentzen, Ivaylo Gentschev, Peter Michael Jakob, Aladar A Szalay

Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody

使用表达抗 VEGF 单链抗体的溶瘤痘苗病毒 GLV-1h109 对犬肿瘤进行病毒治疗

Sandeep S Patil, Ivaylo Gentschev, Marion Adelfinger, Ulrike Donat, Michael Hess, Stephanie Weibel, Ingo Nolte, Alexa Frentzen, Aladar A Szalay

Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma

溶瘤痘苗病毒治疗犬软组织肉瘤的临床前评估

Ivaylo Gentschev, Marion Adelfinger, Rafael Josupeit, Stephan Rudolph, Klaas Ehrig, Ulrike Donat, Stephanie Weibel, Nanhai G Chen, Yong A Yu, Qian Zhang, Martin Heisig, Douglas Thamm, Jochen Stritzker, Amy Macneill, Aladar A Szalay